Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Oct 1;130(10):5121-5123.
doi: 10.1172/JCI141317.

Antituberculosis BCG vaccination: more reasons for varying innate and adaptive immune responses

Affiliations
Comment

Antituberculosis BCG vaccination: more reasons for varying innate and adaptive immune responses

S Prentice et al. J Clin Invest. .

Abstract

Bacillus Calmette-Guérin (BCG) vaccination induces variable protection against pulmonary tuberculosis (TB), and a more effective TB vaccine is needed. The potential for BCG to provide protection against heterologous infections, by induction of innate immune memory, is increasingly recognized. These nonspecific responses may substantially benefit public health, but are also variable. In this issue of the JCI, Koeken and de Bree et al. report that BCG reduces circulating inflammatory markers in males but not in females, while de Bree and Mouritis et al. describe how diurnal rhythms affect the degree of BCG-induced innate memory. These studies further delineate factors that influence the magnitude of responses to BCG and may be crucial to harnessing its potential benefits.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: HMD and SP declare that no conflict of interest exists.

Comment on

References

    1. Mangtani P, et al. Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials. Clin Infect Dis. 2014;58(4):470–480. doi: 10.1093/cid/cit790. - DOI - PubMed
    1. Grassly NC, Kang G, Kampmann B. Biological challenges to effective vaccines in the developing world. Philos Trans R Soc Lond B Biol Sci. 2015;370(1671):20140138. doi: 10.1098/rstb.2014.0138. - DOI - PMC - PubMed
    1. Brazier B, McShane H. Towards new TB vaccines. Semin Immunopathol. 2020;42(3):315–331. doi: 10.1007/s00281-020-00794-0. - DOI - PMC - PubMed
    1. Biering-Sørensen S, Jensen KJ, Monterio I, Ravn H, Aaby P, Benn CS. Rapid protective effects of early BCG on neonatal mortality among low birth weight boys: observations from randomized trials. J Infect Dis. 2018;217(5):759–766. doi: 10.1093/infdis/jix612. - DOI - PMC - PubMed
    1. Prentice S, et al. BCG-induced non-specific protection against heterologous infectious disease in Ugandan neonates: an investigator-blind randomised controlled trial. Lancet Infect Dis. In press. - PMC - PubMed